A comprehensive view of Biopharmaceuticals/Biologics. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

AGC Biologics Receives Excellence in Innovation and Leadership by Le Fonti Business News in Italy

Eli Lilly dumps Innovent Biologic's Tyvyt PD-1 inhibitor after FDA rebuff, nixing high-profile Chinese cancer drug

Regeneron reports FDA has accepted its sBLA for Evkeeza evinacumab-dgnb for priority review; Evkeeza treats children with ultra-rare inherited homozygous familial hypercholesterolemia, a form of high cholesterol

Lilly completes acquisition of Akouos, expanding its efforts to help people with genetic diseases; acquisition includes Akouos's portfolio of adeno-associated viral gene therapies to treat inner ear conditions, including sensorineural hearing loss

AstraZeneca withdraws US COVID-19 vaccine application for Vaxzevria, shifts focus to antibody treatment Evusheld; Evusheld is approved in US to prevent COVID in immunocompromised people and in Europe as a preexposure prophylactic and as a treatment

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count